TheEdgeResearch
Home / Stocks / IDTA

IDenta Corp. (IDTA)

OTC Healthcare Medical - Specialties
$0.31 ▲ +0.00%
Market Cap
$1.3M
Sector
Healthcare
Industry
Medical - Specialties
Beta
0.62
52-Wk Range
0.151-0.356
CEO
Amichai Glattstein
Country
IL
Currency
USD

IDenta Corp. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Jerusalem, JM, IL. The stock last traded at $0.31, up 0.00% on the session, giving a market capitalisation of $1.3M. On trailing twelve-month figures it carries a trailing P/E of 8.71, a net margin of 7.6%. Its beta of 0.62 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
8.71
Price / Sales
0.67
Price / Book
1.03
EV / EBITDA
4.89
Gross margin
51.5%
Operating margin
17.6%
Net margin
7.6%
Return on equity
—
Debt / equity
0.51
Current ratio
4.32
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
14
IPO date
2017-07-24
Headquarters
Jerusalem, JM, IL
About IDenta Corp.

IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Nigeria, Canada, and internationally. IDenta Corp. was founded in 2002 and is headquartered in Jerusalem, Israel.

Comparable companies

IDenta Corp. is most often compared with the following Healthcare names:

ALIDAPPBCNNACPMDENZCEPGNFIVROMODVQSZLSFVCNX
More research on IDTA
IDTA technical analysis IDTA TheEdge Score Compare against peers
Open full interactive analysis & DCF →